Brief: Propanc Biopharma Registers Resale Of 6,500,000 Shares Of Common Stock - SEC Filing
05/10/2026 22:55
BRIEF-Propanc Biopharma Registers Resale Of 6,500,000 Shares Of Common Stock - SEC Filing Oct 5 (Reuters) - Propanc Biopharma Inc PPCB.O:
PROPANC BIOPHARMA - REGISTERS RESALE OF 6,500,000 SHARES OF COMMON STOCK - SEC FILING
Source text: [ID:n0001493152-26-045770]
Further company coverage: PPCB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Propanc Biopharma
See all newsNASDAQ TRADE HALT HALT NEWS PENDING AT 09:29 PM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Propanc Biopharma Reports Data Showing 90% Tumor Growth Inhibition With Prp In Pancreatic Cancer Models, Contrasting Profile With Revolution Medicines’ Daraxonrasib
Brief: Propanc Biopharma Registers Resale Of 6,500,000 Shares Of Common Stock - SEC Filing
Brief: Propanc Biopharma To File Cta In Australia For Phase 1B Study In 30–40 Advanced Cancer Patients